Which patients with myelofibrosis should receive ruxolitinib therapy? ELN-SIE evidence-based recommendations von Marchetti, M, Barosi, G, Cervantes, F, Birgegård, G, Griesshammer, M, Harrison, C, Hehlmann, R, Kiladjian, J-J, Kröger, N, McMullin, M F, Passamonti, F, Vannucchi, A, Barbui, T

Volltext

High incidence of iron depletion and restless leg syndrome (RLS) in regular blood donors: intravenous iron sucrose substitution more effective than oral iron von Birgegård, G., Schneider, K., Ulfberg, J.

Volltext

Five-year follow-up of survival and relapse in patients who received cryotherapy during high-dose chemotherapy for stem cell transplantation shows no safety concerns von SVANBERG, A., ÖHRN, K., BIRGEGÅRD, G.

Volltext

Treatment of high risk ET – data from the EXELS study von Birgegård, G, Besses, C, Griesshammer, M, Gugliotta, L, Harrison, C, Hamdani, M, Achenbach, H, Kiladjian, J.-J

Volltext

Addition of intravenous iron to epoetin beta increases hemoglobin response and decreases epoetin dose requirement in anemic patients with lymphoproliferative malignancies : a rando... von HEDENUS, M, BIRGEGARD, G, NÄSMAN, P, AHLBERG, L, KARLSSON, T, LAURI, B, LUNDIN, J, LÄRFARS, G, ÖSTERBORG, A

Volltext

The role of iron supplementation during epoietin treatment for cancer-related anemia von Hedenus, M., Birgegård, G.

Volltext

Treatment-Related Risk Factors for Transformation to Acute Myeloid Leukemia and Myelodysplastic Syndromes in Myeloproliferative Neoplasms von BJÖRKHOLM, Magnus, DEROLF, Asa R, MARKEVÄRN, Berit, NILSSON, Lars, SAMUELSSON, Jan, GRANATH, Fredrik, LANDGREN, Ola, HULTCRANTZ, Malin, KRISTINSSON, Sigurdur Y, EKSTRAND, Charlotta, GOLDIN, Lynn R, ANDREASSON, Björn, BIRGEGARD, Gunnar, LINDER, Olle, MALM, Claes

Volltext

The outcome of allo-HSCT for 92 patients with myelofibrosis in the Nordic countries von Abelsson, J, Merup, M, Birgegård, G, WeisBjerrum, O, Brinch, L, Brune, M, Johansson, P, Kauppila, M, Lenhoff, S, Liljeholm, M, Malm, C, Remes, K, Vindelöv, L, Andréasson, B

Volltext

Adverse effects and benefits of two years of anagrelide treatment for thrombocythemia in chronic myeloproliferative disorders von Birgegard, G, Bjorkholm, M, Kutti, J, Larfars, G, Lofvenberg, E, Markevarn, B, Merup, M, Palmblad, J, Mauritzson, N, Westin, J, Samuelsson, J

Volltext

Clinical end points for drug treatment trials in BCR-ABL1-negative classic myeloproliferative neoplasms: consensus statements from European LeukemiaNET (ELN) and Internation Workin... von Barosi, G, Tefferi, A, Besses, C, Birgegard, G, Cervantes, F, Finazzi, G, Gisslinger, H, Griesshammer, M, Harrison, C, Hehlmann, R, Hermouet, S, Kiladjian, J-J, Kröger, N, Mesa, R, Mc Mullin, M F, Pardanani, A, Passamonti, F, Samuelsson, J, Vannucchi, A M, Reiter, A, Silver, R T, Verstovsek, S, Tognoni, G, Barbui, T

Volltext

P0101 RLS symptoms in blood donors are improved by iron sucrose injections von Ulfberg, J, Schneider, K, Birgegård, G

Volltext

A unified definition of clinical resistance/intolerance to hydroxyurea in essential thrombocythemia : results of a consensus process by an international working group von BAROSI, G, BESSES, C, HASSELBALCH, H, LENGFELDER, E, REILLY, J. T, MICHIELS, J. J, BARBUI, T, BIRGEGARD, G, BRIERE, J, CERVANTES, F, FINAZZI, G, GISSLINGER, H, GRIESSHAMMER, M, GUGLIOTTA, L, HARRISON, C

Volltext

Philadelphia chromosome-negative classical myeloproliferative neoplasms: revised management recommendations from European LeukemiaNet von Barbui, Tiziano, Tefferi, Ayalew, Vannucchi, Alessandro M., Passamonti, Francesco, Silver, Richard T., Hoffman, Ronald, Verstovsek, Srdan, Mesa, Ruben, Kiladjian, Jean-Jacques, Hehlmann, Rȕdiger, Reiter, Andreas, Cervantes, Francisco, Harrison, Claire, Mc Mullin, Mary Frances, Hasselbalch, Hans Carl, Koschmieder, Steffen, Marchetti, Monia, Bacigalupo, Andrea, Finazzi, Guido, Kroeger, Nicolaus, Griesshammer, Martin, Birgegard, Gunnar, Barosi, Giovanni

Volltext

Too-low iron doses and too many dropouts in negative iron trial? von Aapro, Matti, Beguin, Yves, Birgegård, Gunnar, Gascón, Pere, Hedenus, Michael, Osterborg, Anders

Volltext

Change in student attitudes to medical school after the introduction of problem-based learning in spite of low ratings von Birgegård, Gunnar, Lindquist, Ulla

Volltext

THU0061 Anemia in patients with rheumatoid arthritis: A cross-sectional study von Back, J., Baecklund, E., Birgegard, G.

Volltext

Philadelphia-Negative Classical Myeloproliferative Neoplasms: Critical Concepts and Management Recommendations From European LeukemiaNet von BARBUI, Tiziano, BAROSI, Giovanni, KILADJIAN, Jean-Jacques, KRÖGER, Nicolaus, MESA, Ruben, MCMULLIN, Mary F, PARDANANI, Animesh, PASSAMONTI, Francesco, VANNUCCHI, Alessandro M, REITER, Andreas, SILVER, Richard T, VERSTOVSEK, Srdan, BIRGEGARD, Gunnar, TEFFERI, Ayalew, CERVANTES, Francisco, FINAZZI, Guido, GRIESSHAMMER, Martin, HARRISON, Claire, HASSELBALCH, Hans Carl, HEHLMANN, Rudiger, HOFFMAN, Ronald

Volltext

Beta-globin mRNA increases rapidly during erythropoietin treatment von HAGBERG, A., BARBANY, G., LANDEGREN, U., BIRGEGÅRD, G.

Volltext

Five-year follow-up of survival and relapse in patients who received cryotherapy during high-dose chemotherapy for stem cell transplantation shows no safety concerns: Oral cryother... von SVANBERG, A., ÖHRN, K., BIRGEGÅRD, G.

Volltext

PSY98 - COST-EFFECTIVENESS ANALYSIS OF FERRIC MALTOL VERSUS FERRIC CARBOXYMALTOSE FOR THE TREATMENT OF IRON DEFICIENCY ANAEMIA IN IBD PATIENTS IN SWEDEN AND FINLAND von Hjelmgren, J., Ericson, O., Niska, P., Kukkonen, P., Birgegård, G.

Volltext